Concepedia

Li Tang

LT

Statistics

Publications

5

Citations

121

H-Index

5

Active since

2010

Affiliations

Nanjing University of Chinese Medicine(Current)

Li Tang is an author at Nanjing University of Chinese Medicine specializing in pharmacology, inflammation, and cell biology.

Publications per year

2010–2021

5

Publications

5

Preventive Effect of Notch Signaling Inhibition by a γ-Secretase Inhibitor on Peritoneal Dialysis Fluid-Induced Peritoneal Fibrosis in Rats

Fengxin Zhu, Li Tang, Fanghua Qiu et al. · American Journal Of Pathology · 2010 · 53 citations · Full text

Life Sciences, Cell Biology, Pharmacology +11

Yi-Qi-Jian-Pi formula modulates the PI3K/AKT signaling pathway to attenuate acute-on-chronic liver failure by suppressing hypoxic injury and apoptosis in vivo and in vitro

Li Tang, Feixia Wang, Lingyan Xiao et al. · Journal of Ethnopharmacology · 2021 · 25 citations

Life Sciences, Cell Biology, Pharmacology +15

Impact of high-dose rate radiotherapy on B and natural killer (NK) cell polarization in peripheral blood mononuclear cells (PBMCs) via inducing non-small cell lung cancer (NSCLC)-derived exosomes

Qianqian Lei, Jiang-Dong Sui, Jin Fu et al. · Translational Cancer Research · 2021 · 17 citations · Full text

Medicine, Immunology, Oncology +14

Upregulation of RIP3 promotes necroptosis via a ROS‑dependent NF‑κB pathway to induce chronic inflammation in HK‑2 cells

Junjun Wei, Liangliang Chen, Duidui Wang et al. · Molecular Medicine Reports · 2021 · 15 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro

Feixia Wang, Li Tang, Baoyu Liang et al. · Frontiers in Pharmacology · 2021 · 11 citations · Full text

Veterinary Medicine, Pathobiology, Pharmacology +16

1–5 of 5